Key Details
Price
$16.01Annual Revenue
$151.00 KAnnual ROE
-10.89%Beta
2.03Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
19 Nov '24 Wells Fargo
Overweight19 Nov '24 TD Cowen
Buy19 Nov '24 JP Morgan
Overweight19 Nov '24 Cantor Fitzgerald
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Septerna doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering
SEPN
globenewswire.com30 October 2024
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery, today announced the closing of its upsized initial public offering (IPO) of 18,400,000 shares of its common stock at a public offering price of $18.00 per share, which includes an additional 2,400,000 shares issued upon the full exercise by the underwriters of their option to purchase additional shares. All of the shares were offered by Septerna.
FAQ
- What is the primary business of Septerna?
- What is the ticker symbol for Septerna?
- Does Septerna pay dividends?
- What sector is Septerna in?
- What industry is Septerna in?
- What country is Septerna based in?
- Is Septerna in the S&P 500?
- Is Septerna in the NASDAQ 100?
- Is Septerna in the Dow Jones?
- When does Septerna report earnings?
- Should I buy Septerna stock now?
What is the primary business of Septerna?
Septerna is a biotechnology company focused on developing innovative therapies for diseases by harnessing the power of G protein-coupled receptors (GPCRs) to create new treatment options.
What is the ticker symbol for Septerna?
The ticker symbol for Septerna is NASDAQ:SEPN
Does Septerna pay dividends?
No, Septerna does not pay dividends
What sector is Septerna in?
Septerna is in the Healthcare sector
What industry is Septerna in?
Septerna is in the Biotechnology industry
What country is Septerna based in?
Septerna is headquartered in United States
Is Septerna in the S&P 500?
No, Septerna is not included in the S&P 500 index
Is Septerna in the NASDAQ 100?
No, Septerna is not included in the NASDAQ 100 index
Is Septerna in the Dow Jones?
No, Septerna is not included in the Dow Jones index
When does Septerna report earnings?
The date for Septerna's next earnings report has not been announced yet
Should I buy Septerna stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions